Overall, these data demonstrate that ectopic Cdx2 expression collaborates with Flt3ITD/+ in hematopoietic cells to accelerate lethal myeloid disease but is insufficient for AML transformation. This evidence concerns the gene CDX2 and acute myeloid leukemia.